|
|
Vaccine Detail
|
Newcastle disease virus lysate |
| Vaccine Information |
- Vaccine Name: Newcastle disease virus lysate
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0004612
- Type: lysate of cell lines
- Status: Research
- CD80
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Preparation: possible value in delaying the progression of malignant melanoma with palpable regional node disease (Stage II) to disseminated melanoma (Stage III). This Phase II study was carried out in a group of 32 patients following therapeutic lymphadenectomy (Cassel et al., 1983).
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
|
| References |
Cassel et al., 1983: Cassel WA, Murray DR, Phillips HS. A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate. Cancer. 1983; 52(5); 856-860. [PubMed: 6871827].
|
|
